Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits

Acta Diabetologica

Volumn 40, Issue 4, 2003, Pages 187-192

  Coscelli, C ^a   Iacobellis, G ^b   Calderini, C ^a   Carleo, R ^c   Gobbo, M ^c   Di Mario, U ^b   Leonetti, F ^b   Galluzzo, A ^d   Pirrone, V ^d   Lunetta, M ^e   Casale, P ^e   Paleari, F ^f   Falcelli, C ^f   Valle, D ^g   Camporeale, A ^g   Merante, D ^g  

^a Parma Hospital   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c San Gennaro Hospital   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e Ospedale Canizzaro   (Italy)

^f SAN GERARDO HOSPITAL   (Italy)

^g ELI LILLY   (Italy)

Author keywords

Humalog Mix25; Type 2 diabetes

Indexed keywords

HUMALOG MIX25; HUMAN INSULIN; INSULIN; INSULIN LISPRO; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIET; FEMALE; HUMAN; INJECTION; INSULIN BLOOD LEVEL; INSULIN TREATMENT; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZATION;

CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; EATING; FEMALE; FOOD HABITS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; ITALY; MALE; MIDDLE AGED; RESEARCH DESIGN; TIME FACTORS;

EID: 10744233670     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0110-2     Document Type: Article

References (10)

1. Radziuk JR (1996) Neutral protamine Lispro: activity profile of s.c. administration with and without admixture of soluble lispro. Diabetologia 39[Suppl 1]:A224
2. Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L (1998) Time action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 21:800-803
3. Koivisto VA, Tuominen JA, Ebeling P (1999) Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients. Diabetes Care 22:459-462
4. Roach P, Yue L, Arora V (1999) Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin Lispro formulation. Humalog Mix25 Study Group. Diabetes Care 22:1258-1261
5. Roach P, Koledova E, Metcalfe S, Hultman C, Milicevic Z (2001) Romania/Russia Mix25 Study Group. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide. Clin Ther 23:1732-1744
6. Roach P, Trautmann M, Arora V, Sun B, Anderson JH Jr (1999) Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix 50. Clin Ther 21:523-534
7. Avignon A, Radauceanu A, Monnier L (1997) Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822-1826
8. 1C. Diabetes Care 23:1236-1241
9. Herz M (1999) Clinical update on Humalog Mix25, a novel pre-mixed formulation of insulin lispro and NPL. Int J Clin Pract 104[Suppl]:8-13
10. Malone JK, Yang H, Woodworth JR, Huang J, Campaigne BN, Halle JP, Yale JF, Grossman LD (2000) Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes. Diabetes Metab 26:481-487